Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A new animal model for Machado Joseph disease involves yet another brain area in the disorder

14.04.2008
Gabinete de Planeamento, Estratégia, Avaliação e Relações Internacionais / Ministério da Ciência, Tecnologia e Ensino Superior

Machado Joseph disease (MJD) is a neurodegenerative disorder associated with deposits of an aberrant form of the protein ataxin-3 in the brain. The disease is also fatal and the most common hereditary motor neurodegenerative disease in many countries.

Despite this, not much is known about MJD including the neurological basis of some of its symptoms, which cannot be linked to the brain damage found in patients. But now, researchers in Portugal and France using a new animal model of the disease were able to show, for the first time, that MJD also affects the striatum, a brain area associated with movement and balance control. These new findings, just published as advance online publication in the journal Human Molecular Genetics, finally clarify the cause of previously unexplained symptoms, such as muscle twisting and abrupt dance-like movements of the limbs.

The research helps to understand better a still incurable pathology while also providing a new animal model to study the disease as well as potential treatments.

MJD, also called spinocerebellar ataxia type 3, belongs to a group of disorders linked to an abnormal repetition of three nucleotides (nucleotides are the DNA building blocks) within a gene. The altered gene produces an abnormal protein, which, incapable of working properly, accumulates instead in insoluble deposits in the patients’ brain and is linked to the neural death characteristic of these disorders.

In MJD the pathology results from a mutation in the MJD1 gene that encodes a protein called ataxin-3. The name Machado-Joseph comes from two families of Portuguese/Azorean descent who were the first patients identified and, today, disease prevalence is still highest among people with a link to Azores. In fact, disease incidence among immigrants of Portuguese ancestry in New England is 1 in 4,000 while in the Azores island, Flores is even higher - 1 in 140. Symptoms include increasing limb weakness (ataxia means lack of muscle control) and widespread clumsiness, difficulty with speech and a general loss of motor control that eventually confines the patient to a wheelchair and, in most severe cases, leads to premature death. Although the disease has been discovered in the 1970s much is still unknown including its cause and also the reason behind many of its symptoms as they do not seem to relate to the brain areas damaged by the disease.

In order to better understand this and because animal models that mimic closely the pathology are necessary Sandro Alves, Nicole Déglon, Luis Pereira de Almeida and colleagues working at the University of Coimbra, Coimbra, Portugal, and the Institute of Biomedical Imaging (I2BM) and Molecular Imaging Research Center (MIRCen), Fontenay-aux-Roses, France together with others in Switzerland and the USA created a virus that contained in its genome the gene for the mutant form of ataxin-3 and injected it into rats .

The idea was that the virus injected into the rat brain, when inserted into the DNA of the infected cells, would also add the mutant ataxin-3 gene. As result, infected cells would produce mutant ataxin-3 and (hopefully) reproduce a MJD-like disease in these animals that could then be studied.

When injecting the altered virus Alves, Almeida and colleagues chose three different brain areas: the substantia nigra, which was known to be affected by MJD in humans so it could serve as positive control for neurodegeneration - but also the cortex and the striatum areas of the brain, which recent imaging techniques have suggested to be linked to MJD. Control rats were injected with a virus that contained DNA for a normal (no-mutated) version of ataxin-3.

Injection of mutated ataxin-3 into the rats’ substantia nigra replicated some of the motor dysfunction of MJD as well as induced brain degeneration and deposits of mutant protein within the injected area. Mutant ataxin-3 deposits in MJD patients are characteristically insoluble fibrillar structures localised inside of the cell nucleus. In agreement with this the deposits found in the rats’ substantia nigra were insoluble, also localised in the nucleus, and of high molecular weight. Supporting the specificity of this new MJD model animals injected with a virus containing the normal form of ataxin-3 showed even distribution of the protein throughout the cell and no neural death..

When it was established that Alves, Almeida and colleagues’ protocol created a valid animal model for MJD the next step was to inject the virus with mutant or normal proteins into the cortex or the striatum of the rats. The idea was to look for MJD-like behavioural and neurologic symptoms in these animals suggesting an involvement of these areas in MJD. Interestingly, although animals injected in the cortex showed deposits of mutant ataxin3 there was almost no neurodegeration detected. Rats injected in the striatum, however, were very different as they had insoluble mutant ataxin-3 deposits and clear indication of neural changes around these deposits. Most interestingly, the amount of neural dysfunction observed was directly linked to the amount of mutant ataxin-3 gene injected (so dose-dependent) supporting the toxic role of this protein in the disease.

To further confirm that the striatum degeneration was characteristic of MJD the researchers decided to look into the striatum tissues of deceased MJD patient and of a mice model of MJD where animals are genetically modified to produce mutant ataxin-3 throughout the brain. In both cases it was found deposits of mutant ataxin-3 and signs of neuropathology within the striatal tissue.

Sandro Alves, Luis Pereira de Almeida and colleagues’ results finally explain why MJD patients suffer so many times from tightening and twisting of the limb and, although less frequently, of abrupt irregular movements since both motor problems can now be explained by a disruption of the neurological paths in the striatum, a brain area connected to balance and movement. The work also provides a new genetic model to study the disease and possible therapeutic approaches to combat it.

Catarina Amorim | alfa
Further information:
http://hmg.oxfordjournals.org/cgi/content/abstract/ddn106v2

More articles from Health and Medicine:

nachricht A whole-body approach to understanding chemosensory cells
13.12.2017 | Tokyo Institute of Technology

nachricht Research reveals how diabetes in pregnancy affects baby's heart
13.12.2017 | University of California - Los Angeles Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Long-lived storage of a photonic qubit for worldwide teleportation

MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.

Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...

Im Focus: Electromagnetic water cloak eliminates drag and wake

Detailed calculations show water cloaks are feasible with today's technology

Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

Im Focus: Successful Mechanical Testing of Nanowires

With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong

Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

A whole-body approach to understanding chemosensory cells

13.12.2017 | Health and Medicine

Water without windows: Capturing water vapor inside an electron microscope

13.12.2017 | Physics and Astronomy

Cellular Self-Digestion Process Triggers Autoimmune Disease

13.12.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>